Akebia Therapeutics, Inc(NASDAQ:AKBA) 
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of renal therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the tre...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.83
H 1.85
L 1.71
C 1.77
V 6,511,297
10EMA 1.77
20EMA 1.77
60EMA 1.77
120EMA 1.77
250EMA 1.77